Section of Digestive Diseases, West Virginia University School of Medicine, Morgantown, WV, USA.
Dig Dis Sci. 2011 Oct;56(10):2871-8. doi: 10.1007/s10620-011-1708-9. Epub 2011 Apr 22.
BACKGROUND: Reflux-like dyspepsia (RLD), where predominant epigastric pain is associated with heartburn and/or regurgitation, is a common clinical syndrome in both primary and specialty care. Because symptom frequency and severity vary, overlap among gastroesophageal reflux disease (GERD), non-erosive reflux disease (NERD), and RLD, is quite common. The chronic and recurrent nature of RLD and its variable response to proton pump inhibitor (PPI) therapy remain problematic. AIMS: To examine the prevalence of GERD, NERD, and RLD in a community setting using an algorithmic approach and to assess the potential, reproducibility, and validity of a multi-factorial scoring system in discriminating patients with RLD from those with GERD or NERD. METHODS: Using a novel algorithmic approach, we evaluated an outpatient, community-based cohort referred to a gastroenterologist because of epigastric pain and heartburn that were only partially relieved by PPI. After an initial symptom evaluation (for epigastric pain, heartburn, regurgitation, dysphagia), an endoscopy and distal esophageal biopsies were performed, followed by esophageal motility and 24-h ambulatory pH monitoring to assess esophageal function and pathological acid exposure. A scoring system based on presence of symptoms and severity of findings was devised. Data was collected in two stages: subjects in the first stage were designated as the derivation cohort; subjects in the second stage were labeled the validation cohort. RESULTS: The total cohort comprised 159 patients (59 males, 100 females; mean age 52). On endoscopy, 30 patients (19%) had complicated esophagitis (CE) and 11 (7%) had Barrett's esophagus (BE) and were classified collectively as patients with GERD. One-hundred and eighteen (74%) patients had normal esophagus. Of these, 94 (59%) had one or more of the following: hiatal hernia, positive biopsy, abnormal pH, and/or abnormal motility studies and were classified as patients with NERD. The remaining 24 patients (15%) had normal functional studies and were classified as patients with RLD. Utilizing the scoring system a total score was calculated for each patient and effectively distinguished patients with GERD (mean score 9), NERD (mean score 6), and RLD (mean score 3). Receiver operating characteristic (ROC) curves confirmed the optimization of the model, particularly in RLD (P = 0.0001, 95% CI: 0.91-0.98). CONCLUSION: In a community cohort of patients presenting with heartburn and epigastric pain partly refractory to empiric PPI therapy, the prevalence of CE was 19%, BE 7%, NERD 59%, and RLD 15%. An algorithmic approach coupled with a novel scoring system, effectively distinguishes GERD from NERD and RLD and facilitates further management decisions. This novel and simple scoring system is both reproducible and validated as a diagnostic aid in evaluating patients presenting with both epigastric pain and heartburn.
背景:反流样消化不良(RLD),主要表现为上腹痛,伴有烧心和/或反流,是初级保健和专科保健中常见的临床综合征。由于症状的频率和严重程度不同,胃食管反流病(GERD)、非糜烂性反流病(NERD)和 RLD 之间存在相当大的重叠。RLD 的慢性和复发性特征及其对质子泵抑制剂(PPI)治疗的可变反应仍然是一个问题。
目的:使用算法方法检查社区环境中 GERD、NERD 和 RLD 的患病率,并评估多因素评分系统在区分 RLD 患者与 GERD 或 NERD 患者方面的潜在性、可重复性和有效性。
方法:我们使用一种新的算法方法,评估了因上腹痛和烧心而被转诊给胃肠病学家的门诊、社区为基础的队列,这些症状仅部分被 PPI 缓解。在进行初始症状评估(上腹痛、烧心、反流、吞咽困难)后,进行内镜检查和远端食管活检,然后进行食管动力和 24 小时动态 pH 监测,以评估食管功能和病理性酸暴露。制定了一个基于症状存在和严重程度的评分系统。数据分两个阶段收集:第一阶段的受试者被指定为推导队列;第二阶段的受试者被标记为验证队列。
结果:总队列包括 159 名患者(59 名男性,100 名女性;平均年龄 52 岁)。在内镜检查中,30 名患者(19%)有复杂的食管炎(CE)和 11 名(7%)有 Barrett 食管(BE),被归类为 GERD 患者。118 名患者(74%)的食管正常。其中 94 名(59%)有以下一种或多种情况:食管裂孔疝、阳性活检、异常 pH 值和/或异常动力研究,并被归类为 NERD 患者。其余 24 名(15%)患者的功能研究正常,被归类为 RLD 患者。利用评分系统为每位患者计算了一个总评分,并有效地区分了 GERD(平均评分 9)、NERD(平均评分 6)和 RLD(平均评分 3)患者。受试者工作特征(ROC)曲线证实了该模型的优化,特别是在 RLD 中(P=0.0001,95%CI:0.91-0.98)。
结论:在一个因经验性 PPI 治疗部分缓解而出现烧心和上腹痛的社区患者队列中,CE 的患病率为 19%,BE 为 7%,NERD 为 59%,RLD 为 15%。一种算法方法结合一种新的评分系统,有效地将 GERD 与 NERD 和 RLD 区分开来,并有助于进一步的管理决策。这种新的、简单的评分系统是一种既具有可重复性又具有验证性的诊断辅助工具,可用于评估同时出现上腹痛和烧心的患者。
Aliment Pharmacol Ther. 2018-10-7
World J Gastroenterol. 2012-8-28
Clin Gastroenterol Hepatol. 2022-5
Aliment Pharmacol Ther. 2013-7-29
Z Gerontol Geriatr. 2017-2
Clin Gastroenterol Hepatol. 2015-5
World J Gastroenterol. 2013-5-28
Gastroenterology. 2006-4
Aliment Pharmacol Ther. 2004-11-15
Aliment Pharmacol Ther. 2004-7
J Clin Gastroenterol. 2004-7
Aliment Pharmacol Ther. 2003-7-15